Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
New Post
Indonesia-based PT Telkom discloses two U.S. investigations, including an FCPA inquiry
May 1, 2025
News Alert
New Post
Merit Medical Systems discloses SEC inquiry into its China-based subsidiary
May 1, 2025
News Alert
New Post
Dutch authorities charge Damen Shipyards with bribery and sanctions-related offenses
April 29, 2025
News Alert